Clinical Trials Directory

Trials / Terminated

TerminatedNCT01477697

Effects of Omega-3 Fatty Acid Supplementation on Inflammatory Response in Multisystem Trauma Patients

Status
Terminated
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
12 (actual)
Sponsor
University of Cincinnati · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study will evaluate the effects of omega-3 fatty acid supplementation on inflammation in trauma patients. The main hypothesis is that such supplementation will reduce the presence of biomarkers of systemic inflammation, as compared to placebo

Detailed description

This prospective, randomized study will evaluate the effects of omega-3 fatty acid supplementation on inflammatory response in multi-injured trauma patients. Its primary objective is to compare the intensity of inflammation between an active omega-3 group and a placebo group.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTOmega-350 mg/kg per day of omega-3 fatty acids
DIETARY_SUPPLEMENTPlacebo50 mg/kg per day of placebo equivalent

Timeline

Start date
2011-06-01
Primary completion
2012-11-01
Completion
2012-11-01
First posted
2011-11-22
Last updated
2013-02-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01477697. Inclusion in this directory is not an endorsement.

Effects of Omega-3 Fatty Acid Supplementation on Inflammatory Response in Multisystem Trauma Patients (NCT01477697) · Clinical Trials Directory